MedPath

Acupuncture for the treatment of hot flashes in patients with breast cancer receiving antiestrogen therapy

Not Applicable
Completed
Conditions
Neoplasms
Registration Number
KCT0007829
Lead Sponsor
Comprehensive & Integrative Medicine Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
30
Inclusion Criteria

? moderate or severe hot flashes symptoms according to the definition of the Food and Drug Administration
? an average of 3 or more hot flashes per week during the 1-week period before study entry
? voluntary participation
? follow-up for the duration of the study
? cessation of HRT or other pharmacologic or alternative treatments for hot flashes at least 4 weeks before the trial, if such treatments were used

Exclusion Criteria

? pharmacologic or other alternative treatment for hot flashes during the trial
? serious medical or psychiatric conditions making participation in the trial unsuitable
? hot flashes caused by menopause without antiestrogen therapy

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
severity of hot flashes ? visual analogue scale (VAS) ? total hot flash score
Secondary Outcome Measures
NameTimeMethod
QoL of the participants: the EORTC QLQ-C30 version 3.0 questionnaire and the EORTC QLQ-BR23
© Copyright 2025. All Rights Reserved by MedPath